Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancer

Fig. 1

ERBB2 as target of miR-1296-5p. a The seed sequence of miR-1296-5p is complementary to the 3′-UTR of ERBB2. b, c Luciferase assay showing reduction in reporter activity (relative luciferase units) after co-transfection of ERBB2-3′UTR with miR-1296-5p in SK-BR-3 or BT-474 cells. d, e Western blot analysis showing suppression of ERBB2 protein levels in SK-BR-3 or BT-474 cells after miR-1296-5p overexpression

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us